Fig. 3

PEDF protects endothelial permeability through the ATGL receptor. a Flow cytometric analysis of CD144 expression levels after addition of the PEDF receptor inhibitor Atglistatin. b Endothelial cell permeability analysis in the presence of Atglistatin; c WB analysis of the expression of endothelial cell junction molecule occludin after addition of PEDF receptor inhibitor Atglistatin (n = 3, * p < 0.05, ** p < 0.01, *** p < 0.001)